Egbuna Ogo - Clin Dev Bone Therapeut Area, Amgen Inc

基本信息

浏览量：9

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 51 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults

Ogo Egbuna,Vincent Audard,George Manos,Simon Tian, Fanuel Hagos,Glenn M Chertow

Glomerular diseasesno. 1 (2024): 64-73

引用0浏览0WOS引用

Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

Ogo Egbuna,Brandon Zimmerman,George Manos,Anne Fortier, Madalina C Chirieac,Leslie A Dakin,David J Friedman,Kate Bramham,Kirk Campbell,Bertrand Knebelmann,Laura Barisoni,Ronald J Falk,Debbie S Gipson,Michael S Lipkowitz,Akinlolu Ojo,Mark E Bunnage,Martin R Pollak,David Altshuler,Glenn M Chertow

The New England journal of medicineno. 11 (2023): 969-979

引用8浏览0WOS引用

APOL1 INHIBITION BY VX-147 AS A TARGETED THERAPY FOR APOL1-MEDIATED KIDNEY DISEASE

Martin Pollak,David Friedman,Laura Barisoni,Ronald Falk,Debbie Gipson,Michael Lipkowitz,Akinlolu Ojo, Madalina Chirieac, Cong Xu,Anne Fortier,Ogo Egbuna,Mark Bunnage,Glenn Chertow

AMERICAN JOURNAL OF KIDNEY DISEASES（2022）

引用0浏览0引用

APOL1 Genotyping and Proteinuric Kidney Disease

Bertrand Knebelmann,Kate Bramham,Kieran Mccafferty,Mohamad Zaidan,Pablo Antonio Urena Torres,Vincent Audard,Jean Jacques Boffa, Thomas Powell,Nauman Shahid, Diego Echeverri, Christopher Provenzano, John Bauman, Aurelia Zamauskaite, Irisz Delestre-Levai, Yuan Yang, Silva Krause, Anna Carolina Ferreira,Ogo Egbuna,Glenn Chertow

Journal of the American Society of Nephrologyno. 11S (2022): 182-182

引用0浏览0引用

Romosozumab in Skeletally Mature Adults with a Fresh Unilateral Tibial Diaphyseal Fracture

Mohit Bhandari,Emil H. Schemitsch,Theofilos Karachalios,Parag Sancheti,Rudolf W. Poolman,John Caminis,Nadia Daizadeh,Ricardo E. Dent-Acosta,Ogo Egbuna,Arkadi Chines,Theodore Miclau

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME（2020）

引用26浏览0WOS引用

A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures

Emil H. Schemitsch,Theodore Miclau,Theofilos Karachalios,Lauren L. Nowak,Parag Sancheti,Rudolf W. Poolman,John Caminis,Nadia Daizadeh,Ricardo E. Dent-Acosta,Ogo Egbuna,Arkadi Chines,Judy Maddox,Andreas Grauer,Mohit Bhandari

Journal of bone and joint surgery American volume/The Journal of bone and joint surgery American v...（2020）

引用50浏览0WOS引用

Pharmacokinetic/pharmacodynamic and Safety Study of a Single Dose of Evolocumab 140 Mg in Healthy Chinese Subjects

Hong Lu,Zhigang Yu,Cheng-Pang Hsu,Brian Tomlinson,Andrea On Yan Luk,Ogo Egbuna,Jihua Wu,Bassam Abosaleem,Jitesh Rana,Maria Laura Monsalvo

International Journal of Clinical Pharmacology and Therapeutics（2020）

引用0浏览0WOS引用

A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of Evolocumab in Healthy Chinese Subjects

Chao Liu,Hong Lu,Fei Yuan,Wei-Li Chen,Hong-Rong Xu,Hui Li,Cheng-Pang Hsu,Ogo Egbuna,Jihua Wu,Clapton Dias,Bassam Abosaleem,Jitesh Rana,Maria Laura Monsalvo,Xue-Ning Li,Zhigang Yu

Clinical Pharmacology Advances and Applications (2019): 145-153

引用3浏览0WOS引用

Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and Safety

Edward Lee,John R. Gibbs,Maurice G. Emery,Geoffrey Block,Scott M. Wasserman,Lisa Hamilton,Sreeneeranj Kasichayanula, Patrick Hanafin,Ransi Somaratne,Ogo Egbuna

Clinical Pharmacology in Drug Development（2019）

引用7浏览0WOS引用

S17 Ivacaftor Treatment in Patients 6 to <12 Months Old with Cystic Fibrosis with a CFTR Gating Mutation: Results of a 2-Part, Single-Arm, Phase 3 Study

Janet Stocks,Wang Lt,Paul Panorchan,Daniel Campbell,Simon Tian,Mark Higgins,Ogo Egbuna,Charlotte McKee,Margaret Rosenfeld

semanticscholar

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn